Literature DB >> 10894399

A complete kinetic study of GG versus AG plantination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species.

F Legendre1, V Bas, J Kozelka, J C Chottard.   

Abstract

The hairpin-stabilized double-stranded oligonucleotides d(TATGGTATT4ATACCATA) (I) and d(TATAGTATT4ATACTATA) (II) were allowed to react with the three aquated forms of the antitumor drug cisplatin (cis-[PtCl2(NH3)2], 1) which are likely candidates for DNA binding, that is, cis-[PtC1(NH3)2(H2O)]+ (2), cis-[Pt(NH3)2(H2O)2]2+ (3), and its conjugate base cis-[Pt(OH)(NH3)2(H2O)]+ (4). The reaction between I and [Pt(NH3)3(H2O)]2+ (5) was also studied for comparison. All reactions were monitored by HPLC. The platination reactions of I and II were carried out in NaClO4 (0.1M) at 293 K and at a constant pH of 4.5 +/- 0.1 for 2, 3, and 5. The data relative to the platination by 4 were obtained from measurements in unbuffered NaClO4 solutions (0.1M) at a starting pH close to neutrality, where 3 and 4 are present in equilibrium. In this case, a fit function describing the pH-time curve allowed the determination of the actual concentrations of 3, 4, and the dihydroxo complex. The platination rate constants characterizing the bimolecular reactions between either I or II and 2, 3, and 4 were individually determined along with the rate constants for hydrolysis of the chloro-monoadducts and for the chelation reactions of the aqua-monoadducts. The reactivity of compounds 2-5, which have the general formula cis-[Pt(NH3)2(H2O)(Y)]2+/-, decreases in the order 3>4>5>>2, that is, Y= H2O > OH- >NH3 >> Cl-, which is the order of decreasing hydrogen-bond donating ability of Y. Deprotonation of 3 to 4 reduces the reactivity of the platinum complex only by a factor of approximately equals 2, and both complexes discriminate between the different purines of I and II in the same manner. Whereas 3 and 4 react approximately three times faster with the GG sequence of I than with the AG sequence of II, 2 shows a similar reactivity towards both sequences. In view of the well-established preferential binding of cisplatin to GG sequences of DNA in vivo and in vitro, this result suggests that the actual DNA platination species are derived from double hydrolysis of cisplatin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894399     DOI: 10.1002/1521-3765(20000602)6:11<2002::aid-chem2002>3.0.co;2-h

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

Review 1.  Novel metals and metal complexes as platforms for cancer therapy.

Authors:  Michael Frezza; Sarmad Hindo; Di Chen; Andrew Davenport; Sara Schmitt; Dajena Tomco; Q Ping Dou
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

2.  Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatin.

Authors:  Alethia A Hostetter; Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

3.  Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

Authors:  Isabelle Ourliac-Garnier; Anaïs Poulet; Razan Charif; Simon Amiard; Frédérique Magdinier; Keyvan Rezaï; Eric Gilson; Marie-Josèphe Giraud-Panis; Sophie Bombard
Journal:  J Biol Inorg Chem       Date:  2010-02-27       Impact factor: 3.358

4.  Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies.

Authors:  Pilar Ruiz-Sánchez; Christiane König; Stefano Ferrari; Roger Alberto
Journal:  J Biol Inorg Chem       Date:  2010-08-29       Impact factor: 3.358

Review 5.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

6.  Tuning the Reactivity and Bonding Properties of Metal Square-Planar Complexes by the Substitution(s) on the Trans-Coordinated Pyridine Ring.

Authors:  Olga Dvořáčková; Zdeněk Chval
Journal:  ACS Omega       Date:  2020-05-14

7.  Cytotoxicity of Alizarine versus Tetrabromocathecol Cyclometalated Pt(II) Theranostic Agents: A Combined Experimental and Computational Investigation.

Authors:  Gloria Mazzone; Stefano Scoditti; Rossella Caligiuri; Loredana Ricciardi; Emilia Sicilia; Maria Giovanna Lupo; Isabella Rimoldi; Nicolas Godbert; Massimo La Deda; Andreea Ionescu; Mauro Ghedini; Iolinda Aiello; Giorgio Facchetti
Journal:  Inorg Chem       Date:  2022-04-25       Impact factor: 5.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.